Warner Chilcott Logo

Warner Chilcott to Present at the Goldman Sachs Leveraged Finance Conference 2012

| Source: Warner Chilcott

DUBLIN, Ireland, April 25, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the Goldman Sachs Leveraged Finance Conference 2012 on Tuesday, May 1st at 3:30 p.m. EDT.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

Company Contact:
Emily Hill
Investor Relations